CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Elanix Biotechnologies AG Company Snapshot
Elanix Biotechnologies AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Elanix Biotechnologies AG with three other pharmaceutical manufacturers in Europe: N4 Pharma PLC of UNITED KINGDOM (2018 sales of £72,832.00 [US$94,586.92 ] ), Vicore Pharma Holding AB of SWEDEN (508,000.00 Swedish Kronor [US$57,409.08 ] of which 100% was HVB), and Diurnal Group PLC which is based in UNITED KINGDOM (£73,000.00 [US$94,805.10 ] of which 100% was Alkindi).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Elanix Biotechnologies AG
  Stock Performance Chart for Elanix Biotechnologies AG
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): .80
(Figures in Euros )
1 Week -0.6%   13 Weeks -3.6%  
4 Weeks -20.5%   52 Weeks 16.9%  
 
Elanix Biotechnologies AG Key Data:
  Ticker: ELN Country: Germany
  Exchanges: DUS FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 61,753
(Year Ending Jan 2019).
Employees:
  Currency: Euros Market Cap: 6,424,317
  Fiscal Yr Ends: December Shares Outstanding: 8,080,902
  Share Type: Stammaktie Closely Held Shares: 3,377,092
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.